Illumina, Inc. (ILMN)
After hours:
| Previous close | 193.55 |
| Open | 195.71 |
| Bid | 0.00 x 1400 |
| Ask | 0.00 x 800 |
| Day's range | 190.89 - 195.98 |
| 52-week range | 180.00 - 526.00 |
| Volume | |
| Avg. volume | 1,303,432 |
| Market cap | 30.311B |
| Beta (5Y monthly) | 0.93 |
| PE ratio (TTM) | 31.74 |
| EPS (TTM) | 6.11 |
| Earnings date | 25 Apr 2022 - 29 Apr 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 371.38 |
- Zacks
Illumina (ILMN) Gains But Lags Market: What You Should Know
Illumina (ILMN) closed the most recent trading day at $193.93, moving +0.2% from the previous trading session.
- Motley Fool
Why Illumina Stock Is Sinking Today
What happened Shares of Illumina (NASDAQ: ILMN) were sinking 9.5% at 11:33 a.m. ET on Friday. The decline came after the company announced the departure of CFO Sam Samad in a press release issued after market close on Thursday.
- Bloomberg
Illumina Says Grail Deal Won’t Hold Back New Cancer Tests
(Bloomberg) -- Illumina Inc.’s lawyers said that its takeover of cancer detection upstart Grail Inc. would not hamper competition in the nascent field of early-stage testing, as the gene sequencing giant sought to overcome a US antitrust challenge.Most Read from BloombergTarget Tries to Save Itself by Putting Everything on SaleHedge Fund D1 Borrowed Billions for a Hot Bet That Now Faces ReckoningAmazon’s Stock Split Delivers More Than Bargained ForMusk’s Twitter Bid Includes Financier Linked to
